Skip to main content

After closing crowdfunding round, Houston biotech co. FibroBiologics reconsiders IPO route

FibroBiologics co-founder and CEO Pete O’Heeron told the Houston Business Journal the funding would help the company progress towards its eventual listing as a public company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.